A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis
Active, not recruiting · NCT04679870 · Registry updated 2024-04-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 2 | 2024-04-03 | NCT04679870 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Galecto Biotech AB | 2 |
| OPIS s.r.l | 1 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asst Grande Ospedale Metropolitano Niguarda | Milan | Italy | 60 |
| Azienda Ospedaliero-Universitaria Careggi | Florence | Italy | 10 |
| Azienda Ospedaliero-Universitaria San Luigi Gonzaga di Orbassano | Orbassano | Italy | 1 |
| Azienda Socio-Sanitaria Territoriale dei Sette Laghi | Varese | Italy | 1 |
| Heinrich-Heine-University Dusseldorf | Düsseldorf | Germany | 1 |
| Klinikum rechts der Isar der Technischen Universitaet Munchen | München | Germany | 1 |
| MD Andersson Cancer Hospital | Houston | United States | 1 |
| University of Bologna Sant Orsola Malpighi | Bologna | Italy | 1 |
| Universität Leipzig | Leipzig | Germany | 9 |
| Universitätsklinikum Heidelberg | Heidelberg | Germany | 47 |
| Woden Dermatology | Canberra | Australia | 1 |